Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium
The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due...
Gespeichert in:
Veröffentlicht in: | Diabetic medicine 2021-05, Vol.38 (5), p.e14547-n/a |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 5 |
container_start_page | e14547 |
container_title | Diabetic medicine |
container_volume | 38 |
creator | Luk, Andrea O. Y. Ng, Susanna S. S. Holt, Richard I. G. |
description | The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic. |
doi_str_mv | 10.1111/dme.14547 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_33615546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2492281416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</originalsourceid><addsrcrecordid>eNqNkstu1DAUhi0EosPAghdAltiAUFrfcmOBhDJTOqJVpXJbWo5jty6JHeykaHZ9BBZseL0-CQ4zHQESEl7YRzrf-f0fHwPwGKN9HNdB06l9zFKW3wEzzDKWpKzEd8EM5YwkFOV4DzwI4RIhTEpa3gd7lGY4TVk2Az9WXS_kAJ2GjRG1GlSAzsLq9ONqcXP9DZdQ2Aa64UJ5aKxWcjDOvoRnqnd-gNq7DsYcJCRSR86ew7fTtriVmoor4RvjrkSQYys8PDPhMzyMdzofbq6_L0UY4IlSQ4CfVAzfrbveBTN2D8E9LdqgHm3POfhwuHxfHSXHp29W1evjRDJG8yRNJSoKQptal3WjMVaYEV0jlGGEGCZT0wJlhDKWi0JLmWOtCaaUFU0hS0Hn4NVGtx_rTjVS2cGLlvfedMKvuROG_5mx5oKfuyuel2U6Cc_Bs62Ad1_G2APvTJCqbYVVbgycsJKQAjOcRfTpX-ilG72N7XGSYpZnRcFopJ5vKOldCF7pnRmM-DRwHgfOfw08sk9-d78jbyccgRcb4KuqnQ7SKCvVDkPxnQgjeZrGCOFIF_9PV2YQ03eo3GiHWHqwLTWtWv_bMl-cLDfefwKGHNcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514768843</pqid></control><display><type>article</type><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</creator><creatorcontrib>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</creatorcontrib><description>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/dme.14547</identifier><identifier>PMID: 33615546</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Cardiovascular diseases ; Communicable Disease Control - methods ; Comorbidity ; Contact tracing ; Coronaviridae ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - immunology ; COVID-19 - metabolism ; COVID-19 - therapy ; Delivery of Health Care - organization & administration ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - immunology ; Diabetes Mellitus - metabolism ; Diabetes Mellitus - therapy ; Disease transmission ; Endocrinology & Metabolism ; Glycemic Control ; Hand Hygiene ; Hong Kong - epidemiology ; Humans ; Hygiene ; Immunocompromised Host - immunology ; infection ; Infections - epidemiology ; Infections - immunology ; Influenza, Human - epidemiology ; Influenza, Human - immunology ; Life Sciences & Biomedicine ; Masks ; Pancreas ; Pandemics ; Physical Distancing ; Practice Guidelines as Topic ; Public health ; Public Policy ; Review ; Reviews ; Risk ; Risk Factors ; SARS-CoV-2 ; Science & Technology ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Severity of Illness Index ; United Kingdom - epidemiology</subject><ispartof>Diabetic medicine, 2021-05, Vol.38 (5), p.e14547-n/a</ispartof><rights>2021 Diabetes UK</rights><rights>2021 Diabetes UK.</rights><rights>Diabetic Medicine © 2021 Diabetes UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>1</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000624275500001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</citedby><cites>FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</cites><orcidid>0000-0002-5244-6069 ; 0000-0001-8911-6744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdme.14547$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdme.14547$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,782,786,887,1419,27931,27932,39265,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33615546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luk, Andrea O. Y.</creatorcontrib><creatorcontrib>Ng, Susanna S. S.</creatorcontrib><creatorcontrib>Holt, Richard I. G.</creatorcontrib><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><title>Diabetic medicine</title><addtitle>DIABETIC MED</addtitle><addtitle>Diabet Med</addtitle><description>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</description><subject>Cardiovascular diseases</subject><subject>Communicable Disease Control - methods</subject><subject>Comorbidity</subject><subject>Contact tracing</subject><subject>Coronaviridae</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - metabolism</subject><subject>COVID-19 - therapy</subject><subject>Delivery of Health Care - organization & administration</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - immunology</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Diabetes Mellitus - therapy</subject><subject>Disease transmission</subject><subject>Endocrinology & Metabolism</subject><subject>Glycemic Control</subject><subject>Hand Hygiene</subject><subject>Hong Kong - epidemiology</subject><subject>Humans</subject><subject>Hygiene</subject><subject>Immunocompromised Host - immunology</subject><subject>infection</subject><subject>Infections - epidemiology</subject><subject>Infections - immunology</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - immunology</subject><subject>Life Sciences & Biomedicine</subject><subject>Masks</subject><subject>Pancreas</subject><subject>Pandemics</subject><subject>Physical Distancing</subject><subject>Practice Guidelines as Topic</subject><subject>Public health</subject><subject>Public Policy</subject><subject>Review</subject><subject>Reviews</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>SARS-CoV-2</subject><subject>Science & Technology</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Severity of Illness Index</subject><subject>United Kingdom - epidemiology</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkstu1DAUhi0EosPAghdAltiAUFrfcmOBhDJTOqJVpXJbWo5jty6JHeykaHZ9BBZseL0-CQ4zHQESEl7YRzrf-f0fHwPwGKN9HNdB06l9zFKW3wEzzDKWpKzEd8EM5YwkFOV4DzwI4RIhTEpa3gd7lGY4TVk2Az9WXS_kAJ2GjRG1GlSAzsLq9ONqcXP9DZdQ2Aa64UJ5aKxWcjDOvoRnqnd-gNq7DsYcJCRSR86ew7fTtriVmoor4RvjrkSQYys8PDPhMzyMdzofbq6_L0UY4IlSQ4CfVAzfrbveBTN2D8E9LdqgHm3POfhwuHxfHSXHp29W1evjRDJG8yRNJSoKQptal3WjMVaYEV0jlGGEGCZT0wJlhDKWi0JLmWOtCaaUFU0hS0Hn4NVGtx_rTjVS2cGLlvfedMKvuROG_5mx5oKfuyuel2U6Cc_Bs62Ad1_G2APvTJCqbYVVbgycsJKQAjOcRfTpX-ilG72N7XGSYpZnRcFopJ5vKOldCF7pnRmM-DRwHgfOfw08sk9-d78jbyccgRcb4KuqnQ7SKCvVDkPxnQgjeZrGCOFIF_9PV2YQ03eo3GiHWHqwLTWtWv_bMl-cLDfefwKGHNcA</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Luk, Andrea O. Y.</creator><creator>Ng, Susanna S. S.</creator><creator>Holt, Richard I. G.</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5244-6069</orcidid><orcidid>https://orcid.org/0000-0001-8911-6744</orcidid></search><sort><creationdate>202105</creationdate><title>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</title><author>Luk, Andrea O. Y. ; Ng, Susanna S. S. ; Holt, Richard I. G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4437-55c08823dbf9bdf11e142fb0061004120012a0623447a8fcc71ff213348d8c9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiovascular diseases</topic><topic>Communicable Disease Control - methods</topic><topic>Comorbidity</topic><topic>Contact tracing</topic><topic>Coronaviridae</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - metabolism</topic><topic>COVID-19 - therapy</topic><topic>Delivery of Health Care - organization & administration</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - immunology</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Diabetes Mellitus - therapy</topic><topic>Disease transmission</topic><topic>Endocrinology & Metabolism</topic><topic>Glycemic Control</topic><topic>Hand Hygiene</topic><topic>Hong Kong - epidemiology</topic><topic>Humans</topic><topic>Hygiene</topic><topic>Immunocompromised Host - immunology</topic><topic>infection</topic><topic>Infections - epidemiology</topic><topic>Infections - immunology</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - immunology</topic><topic>Life Sciences & Biomedicine</topic><topic>Masks</topic><topic>Pancreas</topic><topic>Pandemics</topic><topic>Physical Distancing</topic><topic>Practice Guidelines as Topic</topic><topic>Public health</topic><topic>Public Policy</topic><topic>Review</topic><topic>Reviews</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>SARS-CoV-2</topic><topic>Science & Technology</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Severity of Illness Index</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luk, Andrea O. Y.</creatorcontrib><creatorcontrib>Ng, Susanna S. S.</creatorcontrib><creatorcontrib>Holt, Richard I. G.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luk, Andrea O. Y.</au><au>Ng, Susanna S. S.</au><au>Holt, Richard I. G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium</atitle><jtitle>Diabetic medicine</jtitle><stitle>DIABETIC MED</stitle><addtitle>Diabet Med</addtitle><date>2021-05</date><risdate>2021</risdate><volume>38</volume><issue>5</issue><spage>e14547</spage><epage>n/a</epage><pages>e14547-n/a</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><abstract>The coronavirus disease 2019 (COVID‐19) pandemic has posed enormous challenges to healthcare systems worldwide. The negative impact of COVID‐19 is widespread and includes not only people who contracted the disease but also those with chronic morbidities such as diabetes whose care is compromised due to diversion of medical resources. People with diabetes are generally more susceptible to infection as a result of altered immunity. People with diabetes have a worse prognosis from COVID‐19 and there is evidence to suggest that severe acute respiratory syndrome coronavirus 2 may directly affect pancreatic function precipitating hyperglycaemic crises. In the United Kingdom, one of the most heavily affected countries, guidelines are in place to unify the management of people with diabetes hospitalized for COVID‐19. Diabetes services are re‐organized to ensure that medical care of people with diabetes is maintained despite resource and other practical constraints. Public health measures including social distancing, hand hygiene and the use of face masks are crucial in containing community transmission of the virus. Hong Kong, one of the most densely populated city in the world, is particularly vulnerable and has in place a stringent containment policy and aggressive contact tracing to ensure public safety during this pandemic.</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>33615546</pmid><doi>10.1111/dme.14547</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-5244-6069</orcidid><orcidid>https://orcid.org/0000-0001-8911-6744</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0742-3071 |
ispartof | Diabetic medicine, 2021-05, Vol.38 (5), p.e14547-n/a |
issn | 0742-3071 1464-5491 |
language | eng |
recordid | cdi_pubmed_primary_33615546 |
source | MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
subjects | Cardiovascular diseases Communicable Disease Control - methods Comorbidity Contact tracing Coronaviridae Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 - metabolism COVID-19 - therapy Delivery of Health Care - organization & administration Diabetes Diabetes mellitus Diabetes Mellitus - epidemiology Diabetes Mellitus - immunology Diabetes Mellitus - metabolism Diabetes Mellitus - therapy Disease transmission Endocrinology & Metabolism Glycemic Control Hand Hygiene Hong Kong - epidemiology Humans Hygiene Immunocompromised Host - immunology infection Infections - epidemiology Infections - immunology Influenza, Human - epidemiology Influenza, Human - immunology Life Sciences & Biomedicine Masks Pancreas Pandemics Physical Distancing Practice Guidelines as Topic Public health Public Policy Review Reviews Risk Risk Factors SARS-CoV-2 Science & Technology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index United Kingdom - epidemiology |
title | Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T13%3A04%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20diabetes%20on%20COVID%E2%80%9019%20and%20other%20infection:%20Report%20from%20the%2022nd%20Hong%20Kong%20Diabetes%20and%20Cardiovascular%20Risk%20Factors%E2%80%94East%20Meets%20West%20Symposium&rft.jtitle=Diabetic%20medicine&rft.au=Luk,%20Andrea%20O.%20Y.&rft.date=2021-05&rft.volume=38&rft.issue=5&rft.spage=e14547&rft.epage=n/a&rft.pages=e14547-n/a&rft.issn=0742-3071&rft.eissn=1464-5491&rft_id=info:doi/10.1111/dme.14547&rft_dat=%3Cproquest_pubme%3E2492281416%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2514768843&rft_id=info:pmid/33615546&rfr_iscdi=true |